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Interventions: To assess pain modulation, rats were orally gavaged at
their EC50 with test compounds in the writhing model of peripheral pain
and hotplate model of CNS-mediated pain. In order to assess abuse lia-
bility, we utilized an operant self-administration procedure, where rats are
required to press a lever to receive an intravenous drug infusion.
Main Outcome Measure(s): The goal of this program is to engineer orally-
available derivatives of CR665.
Results: Lead compound JT09 activates the kappa-opioid receptor with
EC50s in the low nM range, while agonist selectivity for kappa over other
peripheral opioid receptors was >11,000-200,000-fold. Results indicate
that JT09 is as efficacious as morphine in alleviating peripheral pain, while
failing to produce the undesired CNS-mediated effects that bedevils
standard opioid treatments for pain alleviation. In the operant self-
administration procedure, JT09 failed to maintain lever responding, indi-
cating no abuse liability. In contrast, highly salient rewards readily
maintained operant responding. Additionally, JT09 did not promote other
CNS-mediated effects associated with opioids (sedation, dysphoria,
tolerance, addiction).
Conclusion/Discussion: Application of the JT Pharma technology to
CR665 enabled identification of derivatives that exhibit peripheral anal-
gesic activity when dosed orally but do not promote CNS-based effects.
Our lead, JT09, is under further evaluation as an orally-available kappa-
opioid agonist for peripheral pain.
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Perceived Barriers for Occupational Therapists in
Oncology Settings: Results From a National Survey
Leah Stein Duker (University of Southern California), Alix Sleight
Research Objectives: Occupational therapists (OTs) represent an integral
part of the cancer care team. However, conceptualizations of OT for cancer
survivors often focus solely on physical interventions, undermining OT’s
ability to provide care that encompasses the full spectrum of physical and
psychosocial treatments. The purpose of this study is to identify the types
of treatments OTs provide in oncology care.
Design: A survey utilizing snowball sampling was disseminated online to
OTs working in oncology care.
Setting: United States.
Participants: Seventy-two OTs (MZ 37.6years) with an average of
5.5years working in an oncology setting participated; most participants
were female (87%), White/Caucasian (69%), and working with adults
(84%) in inpatient hospitals (79%).
Interventions: N/A.
Main Outcome Measure(s): N/A.
Results: Over 90% of therapists reported that their treatments typically
focused on physical impairment, ADLs, weakness, fatigue, pain, and quality
of life. Treatments focusing on cognitive impairment, emotional difficulties,
and transition to home/home safetywere reported by 70-80%of respondents.
Therapists reported that treatment sessions included activities they did not
bill directly for, including: emotional and social support difficulties (70%),
self-advocacy, quality of life, and body image challenges (w50%), and
caregiver and patient education/training and lifestyle management (w33%).
More than 90% of therapists reported that if there were no barriers, they
would like to address quality of life, emotional difficulties, transition to
home/home safety, and lifestyle management issues in treatments.
Conclusion/Discussion: The majority of OTs do provide physical in-
terventions for their oncology patients. However, therapists also deliver
mental health services and client/caregiver education, commonly reported
unmet needs of cancer survivors, but do not bill directly for this care.
Reimbursement structures should be altered to allow for the direct billing
of mental/psychosocial and educational interventions in OT for the
oncology population.




Perceived Stress Levels May Impact Upper
Extremity Function Among Women Treated for
Breast Cancer
Mary Fisher (University of Dayton), Anne Fleischer, Kimbery Parent,
Renee Roberts, Megan McClure, Lynn Hendricks
Research Objectives: Women treated for breast cancer report ongoing
disability in their involved upper extremity, however, often objective
measures do not appear to explain the level of perceived dysfunction. The
purpose of this study was to investigate the relationship between perceived
stress level, fear of physical activity and self-reported upper extremity
function among women treated for breast cancer.
Design: Observational cohort study.
Setting: General community.
Participants: Twenty-five women with a mean age of 52 years (range 31-
68) diagnosed with Stage 1-3 breast cancer between 12 and 60 months
prior to data collection.
Interventions: Participants completed three patient-reported outcome
scales in a single visit. Data were analyzed with Pearson’s correlation r to
determine if there was a relationship between self-reported upper ex-
tremity function and/or perceived stress level and fear of phys-
ical activity.
Main Outcome Measure(s): Disabilities of the Arm, Shoulder and Hand
(DASH), a 30-item self-report scale of upper extremity function; Perceived
Stress Scale (PSS), a 10-item self-report scale of stress in the past month;
and Fear of Physical Activity/Exercise Scale - Breast Cancer (FPAX-B), a
17-item self-report scale concerning participation in physical activity for
breast cancer survivors.
Results: There was a significant relationship between the DASH and both
the PSS, rZ.074, p (one-tailed) < .001 and FPAX-B, rZ.072, p (one-
tailed) < .001.
Conclusion/Discussion: Results of the study suggest that there is a sig-
nificant positive relationship between the DASH and both the PSS and
FPAX-B among women treated for breast cancer. Perceived stress and fear
of physical activity may be impacting self-reported upper extremity
functional abilities. Further research should be done to investigate the role
of stress and fear of physical activity has on perceived measures of upper
extremity function.
Key Words: Breast Neoplasm, Patient-Reported Outcomes, Upper Ex-
tremity Disability, Fear Of Physical Activity
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Peripheral Neuropathy, Function and Quality of
Life in Adult Survivors of Childhood Acute
Lymphoblastic Leukemia
Mitra Varedi (Stony Brook University), Lu Lu, Carrie Howell,
Robyn Partin, Melissa Hudson, Ching-Hon Pui, Leslie Robison,
Kirsten Ness, Raymond McKenna
Research Objectives: To compare scores on measures of peripheral neu-
ropathy, balance and quality of life (QoL) among adults survivors of
childhood acute lymphoblastic leukemia (ALL) and age-, sex-, and race-
matched community controls. To evaluate the association between neurop-
athy and balance, mobility, walking endurance and QoL among survivors.
Design: Cross Sectional.
Setting: Outpatient.
Participants: 364 adult survivors of childhood ALL,  10 years post
diagnosis, and 364 matched community controls with no cancer history.
Interventions: Not applicable.
Main Outcome Measure(s): Peripheral neuropathy was measured using
the modified Total Neuropathy Score (mTNS), balance using the Sensory
Organization Test (SOT), mobility using Timed Up and Go (TUG),
walking endurance using 6-minute walk and QoL using Medical Outcomes
Survey Short Form-36 (SF-36).
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